Search research articles
Contact Us
Filters
Showing results (271-280 of 368) with videos related to
Page
of 37
Sort By:
Pharmacogenetics and Genomics
|
February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms
Yuqing Liang, Christina L Gersch, Jennifer Lehman, et al.
Neurology
|
April 13, 2000
Functional MR evaluation of temporal and frontal language dominance compared with the Wada test
S Lehéricy, L Cohen, B Bazin, et al.
The Lancet. Diabetes & Endocrinology
|
June 14, 2019
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Thomas R Pieber, Bruce Bode, Ann Mertens, et al.
Journal of Medical Internet Research
|
February 5, 2025
Remote Monitoring of Chemotherapy-Induced Peripheral Neuropathy by the NeuroDetect iOS App: Observational Cohort Study of Patients With Cancer
Ciao-Sin Chen, Michael P Dorsch, Sarah Alsomairy, et al.
British Journal of Clinical Pharmacology
|
June 12, 2012
Pilot study of rosiglitazone as an in vivo probe of paclitaxel exposure
Daniel L Hertz, Christine M Walko, Arlene S Bridges, et al.
BMJ Open Diabetes Research & Care
|
December 15, 2020
Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial
John B Buse, Bruce W Bode, Ann Mertens, et al.
Pharmacogenomics
|
January 7, 2021
Patients carrying DPYD variant alleles have increased risk of severe toxicity and related treatment modifications during fluoropyrimidine chemotherapy
Faisal Shakeel, Fang Fang, Jung Won Kwon, et al.
The Journal of Biological Chemistry
|
May 13, 2008
Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome
John S Lyssand, Mia C DeFino, Xiao-bo Tang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2013
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
D L Hertz, S Roy, A A Motsinger-Reif, et al.
Journal of Patient Safety
|
October 1, 2020
Improvement Initiative to Develop and Implement a Tool for Detecting Drug-Drug Interactions During Oncology Clinical Trial Enrollment Eligibility Screening
Lauren A Marcath, Taylor D Coe, Faisal Shakeel, et al.
Page
of 37
Search research articles
Search
Showing results (271-280 of 368) with videos related to
Sort By:
Page
of 37
Pharmacogenetics and Genomics
|
February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms
Yuqing Liang, Christina L Gersch, Jennifer Lehman, et al.
Neurology
|
April 13, 2000
Functional MR evaluation of temporal and frontal language dominance compared with the Wada test
S Lehéricy, L Cohen, B Bazin, et al.
The Lancet. Diabetes & Endocrinology
|
June 14, 2019
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Thomas R Pieber, Bruce Bode, Ann Mertens, et al.
Journal of Medical Internet Research
|
February 5, 2025
Remote Monitoring of Chemotherapy-Induced Peripheral Neuropathy by the NeuroDetect iOS App: Observational Cohort Study of Patients With Cancer
Ciao-Sin Chen, Michael P Dorsch, Sarah Alsomairy, et al.
British Journal of Clinical Pharmacology
|
June 12, 2012
Pilot study of rosiglitazone as an in vivo probe of paclitaxel exposure
Daniel L Hertz, Christine M Walko, Arlene S Bridges, et al.
BMJ Open Diabetes Research & Care
|
December 15, 2020
Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial
John B Buse, Bruce W Bode, Ann Mertens, et al.
Pharmacogenomics
|
January 7, 2021
Patients carrying DPYD variant alleles have increased risk of severe toxicity and related treatment modifications during fluoropyrimidine chemotherapy
Faisal Shakeel, Fang Fang, Jung Won Kwon, et al.
The Journal of Biological Chemistry
|
May 13, 2008
Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome
John S Lyssand, Mia C DeFino, Xiao-bo Tang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2013
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
D L Hertz, S Roy, A A Motsinger-Reif, et al.
Journal of Patient Safety
|
October 1, 2020
Improvement Initiative to Develop and Implement a Tool for Detecting Drug-Drug Interactions During Oncology Clinical Trial Enrollment Eligibility Screening
Lauren A Marcath, Taylor D Coe, Faisal Shakeel, et al.
Page
of 37